Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions

Citation
M. Naumann et al., Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions, EUR J NEUR, 6, 1999, pp. S111-S115
Citations number
24
Categorie Soggetti
Neurology
Journal title
EUROPEAN JOURNAL OF NEUROLOGY
ISSN journal
13515101 → ACNP
Volume
6
Year of publication
1999
Supplement
4
Pages
S111 - S115
Database
ISI
SICI code
1351-5101(199911)6:<S111:BTTAIT>2.0.ZU;2-U
Abstract
Focal essential hyperhidrosis is a common and often disabling disorder main ly involving the palms, axillae, face, and soles of the feet, Focal hyperhi drosis may also arise from several neurological or internal diseases. Curre nt therapeutic options include topical aluminium chloride salts, systemic a nticholinergic drugs, tap-water iontophoresis, and a number of surgical app roaches. However, none of these are entirely satisfactory, In recent studie s, injection of botulinum toxin type A (BTX-A) into the hyperhidrotic area has proved very effective in reducing or abolishing focal sweating of diffe rent aetiologies without major side effects. BTS-A therefore has the potent ial to replace more invasive therapies. Eur J Neurol 6 (suppl 4):S111-S115 (C) Lippincott Williams & Wilkins.